查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1455194

2024 年心血管植入全球市場報告

Cardiovascular Implants Global Market Report 2024
出版日期: 按訂單生產 | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

心血管植入市場規模預計在未來幾年將顯著成長。預計到 2028 年將以 6.6% 的複合年成長率 (CAGR) 成長至 345.9 億美元。預測期內的預期成長是由個人化醫療方法的採用、對微創手術的重視、心血管研究的全球合作、強調預防性干預的醫療保健政策以及向以患者為中心的心血管護理的轉變所推動的。這被認為是由於。預測期內預計的主要趨勢包括藥物釋放型支架的進步、下一代心臟瓣膜的興起、人工智慧 (AI) 的日益整合、對微創植入技術的重視以及個性化的患者專用植入。無導線心律調節器的出現。

心臟病患病率的預期增加預計將推動未來心血管植入市場的擴張。心臟疾病包括影響心臟和血管的各種疾病，例如冠狀動脈疾病、心臟衰竭、心律不整和瓣膜疾病。冠狀動脈疾病和心臟衰竭等心臟病的流行推動了對支架和心律調節器等心血管植入的需求，因為這些植入在這些疾病的治療中發揮著重要作用。它們支持心臟衰竭患者的心臟和循環，幫助維持規律的心率，並監測心臟活動。例如，2023年4月，英國心臟基金會報告稱，蘇格蘭死於心臟和循環系統疾病的人數從2020年的17,448人增加到2021年的17,639人。此外，英國死於心臟疾病的人數從64,170人上升。因此，心臟病患病率的增加正在推動心血管植入市場的成長。

人口老化的加劇預計將推動未來心血管植入市場的成長。人口老化反映了以60歲及以上人口比例不斷增加為特徵的人口變化。心血管植入在老年人流行的心血管疾病的管理和治療中發揮著重要作用，有助於提高生活品質、延長壽命和改善整體健康。根據世界衛生組織2022年10月的數據，到2030年，全球六分之一的人將超過60歲，到2050年，這數字預計將達到21億。因此，人口老化的加劇已成為推動心血管植入市場成長的關鍵因素。

目錄

第1章執行摘要

第2章 市場特點

第3章 市場趨勢與策略

第4章宏觀經濟情景

  • 高通膨對市場的影響
  • 烏克蘭與俄羅斯戰爭對市場的影響
  • COVID-19 對市場的影響

第5章世界市場規模與成長

  • 全球市場促進因素與限制因素
    • 市場促進因素
    • 市場限制因素
  • 2018-2023 年全球市場規模表現與成長
  • 全球市場規模預測與成長，2023-2028、2033

第6章市場區隔

  • 全球心血管植入市場，依產品、性能及預測細分，2018-2023、2023-2028、2033
  • 冠狀動脈支架
  • 植入式心臟整流去顫器(ICD)
  • 心臟瓣膜
  • 植入式心臟心律調節器
  • 心臟再同步治療 (CRT) 裝置
  • 外周支架
  • 全球心血管植入市場，依材料、性能及預測細分，2018-2023、2023-2028、2033
  • 金屬和合金
  • 聚合物
  • 生物材料
  • 全球心血管植入市場，按應用、性能和預測細分，2018-2023、2023-2028、2033
  • 心律不整
  • 急性心肌梗塞
  • 心肌缺血
  • 其他用途
  • 全球心血管植入市場，按最終用戶細分、績效和預測，2018-2023、2023-2028、2033
  • 醫院
  • 門診手術中心
  • 心臟中心

第 7 章 區域與國家分析

  • 全球心血管植入市場，依地區、績效及預測，2018-2023、2023-2028、2033
  • 全球心血管植入市場，依國家、績效及預測，2018-2023、2023-2028、2033

第8章亞太市場

第9章 中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章 義大利市場

第20章 西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章加拿大市場

第26章 南美洲市場

第27章 巴西市場

第28章 中東市場

第29章 非洲市場

第30章 競爭格局及公司概況

  • 心血管植入市場競爭格局
  • 心血管植入市場公司概況
    • Abbott Laboratories
    • Medtronic PLC
    • Boston Scientific Corporation
    • B. Braun Melsungen AG
    • Edwards Lifesciences Corporation

第31章 其他重大及創新企業

  • WL Gore &Associates Inc.
  • Cook Medical Incorporated
  • Teleflex Incorporated
  • Kyoto Medical Planning Co. Ltd.
  • Abiomed Inc.
  • Livanova PLC
  • BIOTRONIK SE &Co. KG
  • CryoLife Inc.
  • Endologix Inc.
  • Sorin Group
  • Berlin Heart GmbH
  • REVA Medical LLC.
  • Syncardia Systems LLC
  • Elixir Medical Corporation
  • Fortimedix Surgical BV

第32章競爭基準化分析

第 33 章. 競爭對手儀表板

第34章 重大併購

第35章 未來前景與可能性分析

第36章附錄

簡介目錄
Product Code: r16195

Cardiovascular implants are medical devices surgically placed within the cardiovascular system to manage heart and vascular conditions. These devices are strategically inserted into the cardiovascular system to address conditions such as blocked arteries, irregular heart rhythms, or valve defects. The primary goal is to restore normal heart function and improve blood circulation.

The main types of products categorized under cardiovascular implants include coronary stents, implantable cardioverter defibrillators (ICD), heart valves, implanted cardiac pacemakers, cardiac resynchronization therapy (CRT) devices, and peripheral stents. A coronary stent is a small mesh tube inserted into a narrowed or blocked coronary artery to maintain its openness. Various materials, including metals and alloys, polymers, and biological materials, are used in the manufacturing of these implants. They find applications in treating conditions such as arrhythmias, acute myocardial infarction, myocardial ischemia, and others. These cardiovascular implants are utilized by various end-users, including hospitals, ambulatory surgical centers, and cardiac centers.

The cardiovascular implants market research report is one of a series of new reports from The Business Research Company that provides cardiovascular implants market statistics, including cardiovascular implants industry global market size, regional shares, competitors with a cardiovascular implants market share, detailed cardiovascular implants market segments, market trends and opportunities, and any further data you may need to thrive in the cardiovascular implants industry. This cardiovascular implants market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cardiovascular implants market size has grown strongly in recent years. It will grow from $24.81 billion in 2023 to $26.8 billion in 2024 at a compound annual growth rate (CAGR) of 8.0%. The growth observed in the historical period can be attributed to factors such as the aging population and associated cardiovascular risks, lifestyle-related cardiovascular risk factors, advancements in diagnostic technologies, increasing awareness, and screening programs, as well as government initiatives focused on cardiovascular health.

The cardiovascular implants market size is expected to see strong growth in the next few years. It will grow to $34.59 billion in 2028 at a compound annual growth rate (CAGR) of 6.6%. The anticipated growth in the forecast period can be attributed to the adoption of personalized medicine approaches, a focus on minimally invasive procedures, global collaboration in cardiovascular research, healthcare policy emphasis on preventive interventions, and the shift towards patient-centric cardiovascular care. Major trends expected in the forecast period include advancements in drug-eluting stents, the rise of next-generation heart valves, increasing integration of artificial intelligence (AI), a focus on minimally invasive implantation techniques, the development of personalized and patient-specific implants, and the emergence of leadless pacemakers.

The anticipated increase in the prevalence of heart disorders is poised to drive the expansion of the cardiovascular implants market in the future. Heart disorders encompass a range of medical conditions affecting the heart and blood vessels, including coronary artery disease, heart failure, arrhythmias, and valve disorders. The demand for cardiovascular implants, such as stents and pacemakers, is propelled by the prevalence of heart diseases such as coronary artery disease and heart failure, as these implants play a crucial role in treating these conditions. They provide support to the heart and circulation in patients with heart failure, aid in maintaining a regular heart rhythm, and monitor heart activity. For example, in April 2023, the British Heart Foundation reported that the number of deaths in Scotland from heart and circulatory illnesses increased from 17,448 in 2020 to 17,639 in 2021. Moreover, the number of deaths from coronary heart disease in the UK rose from 64,170 in 2020 to 65,579 in 2021. Hence, the growing prevalence of heart disorders is fueling the growth of the cardiovascular implants market.

The increase in the aging population is expected to drive the growth of the cardiovascular implants market in the future. The aging population reflects a demographic shift characterized by a higher proportion of individuals aged 60 and above in a population. Cardiovascular implants play a crucial role in managing and treating cardiovascular diseases prevalent in older individuals, contributing to improved quality of life, increased longevity, and overall better health outcomes. According to the World Health Organization in October 2022, globally, 1 in 6 individuals is projected to be 60 or older by 2030, and this number is expected to reach 2.1 billion elderly people by 2050. Therefore, the rise in the aging population is a key factor driving the growth of the cardiovascular implants market.

The impediment to the growth of the cardiovascular implant market is the high cost associated with left ventricular devices. The incremental cost-effectiveness ratio for destination-therapy left ventricular assist devices (LVAD) over optimal medical management is relatively high. While LVADs improve the quality of life in non-inotrope-dependent heart failure patients, they substantially increase lifetime costs. For example, a study in August 2020 revealed that LVAD patients had higher lifetime costs, with the total cost for the LVAD arm being $551,934 compared to $334,117 for the control group. Consequently, the high cost of left ventricular assist devices poses a restraint on the growth of the cardiovascular implant market.

Leading companies in the cardiovascular implants market are intensifying their focus on incorporating advanced technology, including artificial intelligence (AI), to optimize market profits and enhance precision in patient care and treatment. Advancements in cardiac monitoring technology involve continuous tracking and recording of a patient's heart activity for the diagnosis and management of heart conditions. In June 2023, BIOTRONIK SE & Co. KG launched the BIOMONITOR IV implantable cardiac monitor (ICM), the first globally, combining SmartECG technology with artificial intelligence. This innovation reduces false-positive detections by 86% while retaining 98% accuracy in detecting real episodes. BIOMONITOR IV offers additional benefits, including extended battery life and wireless connectivity for smooth data transmission and remote monitoring, reducing the need for frequent in-person clinic visits.

In April 2023, Abbott Laboratories acquired Cardiovascular Systems Inc. for $890 million, aiming to enhance its solutions for treating vascular disease. This strategic acquisition makes Cardiovascular Systems Inc. a wholly owned subsidiary of Abbott and strengthens Abbott's position in providing innovative solutions for peripheral and coronary vascular disease.

Major companies operating in the cardiovascular implants market report are Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, B. Braun Melsungen AG, Edwards Lifesciences Corporation, W. L. Gore & Associates Inc., Cook Medical Incorporated, Teleflex Incorporated, Kyoto Medical Planning Co. Ltd., Abiomed Inc., Livanova PLC, BIOTRONIK SE & Co. KG, CryoLife Inc., Endologix Inc., Sorin Group, Berlin Heart GmbH, REVA Medical LLC., Syncardia Systems LLC, Elixir Medical Corporation, Fortimedix Surgical B.V., AMG International GmbH, CHF Solutions Inc., Proxy Biomedical Ltd., Calon Cardio-Technology Ltd., InspireMD Inc., Neovasc Inc., Shree Pacetronix Ltd., Vascutek Ltd (Terumo Corporation)

North America was the largest region in the cardiovascular implants market in 2023. The regions covered in the cardiovascular implants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cardiovascular implants market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cardiovascular implants market consists of sales of aneurysm stent-grafts, cardiac resynchronization therapy (CRT) devices, ventricular assist devices, and peripheral vascular stents. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cardiovascular Implants Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cardiovascular implants market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cardiovascular implants ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cardiovascular implants market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Product: Coronary Stent; Implantable Cardioverter Defibrillator (ICD); Heart Valve; Implanted Cardiac Pacemaker; Cardiac Resynchronization Therapy (CRT) Devices; Peripheral Stent
  • 2) By Material: Metals and Alloys; Polymers; Biological Materials
  • 3) By Application: Arrhythmias; Acute Myocardial Infarction; Myocardial Ischemia; Other Applications
  • 4) By End-Users: Hospitals; Ambulatory Surgical Centers; Cardiac Centers
  • Companies Mentioned: Abbott Laboratories; Medtronic PLC; Boston Scientific Corporation; B. Braun Melsungen AG; Edwards Lifesciences Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Cardiovascular Implants Market Characteristics

3. Cardiovascular Implants Market Trends And Strategies

4. Cardiovascular Implants Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Cardiovascular Implants Market Size and Growth

  • 5.1. Global Cardiovascular Implants Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Cardiovascular Implants Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Cardiovascular Implants Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Cardiovascular Implants Market Segmentation

  • 6.1. Global Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Coronary Stent
  • Implantable Cardioverter Defibrillator (ICD)
  • Heart Valve
  • Implanted Cardiac Pacemaker
  • Cardiac Resynchronization Therapy (CRT) Devices
  • Peripheral Stent
  • 6.2. Global Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Metals and Alloys
  • Polymers
  • Biological Materials
  • 6.3. Global Cardiovascular Implants Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Arrhythmias
  • Acute Myocardial Infarction
  • Myocardial Ischemia
  • Other Applications
  • 6.4. Global Cardiovascular Implants Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Ambulatory Surgical Centers
  • Cardiac Centers

7. Cardiovascular Implants Market Regional And Country Analysis

  • 7.1. Global Cardiovascular Implants Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Cardiovascular Implants Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Cardiovascular Implants Market

  • 8.1. Asia-Pacific Cardiovascular Implants Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Cardiovascular Implants Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Cardiovascular Implants Market

  • 9.1. China Cardiovascular Implants Market Overview
  • 9.2. China Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Cardiovascular Implants Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Cardiovascular Implants Market

  • 10.1. India Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Cardiovascular Implants Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Cardiovascular Implants Market

  • 11.1. Japan Cardiovascular Implants Market Overview
  • 11.2. Japan Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Cardiovascular Implants Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Cardiovascular Implants Market

  • 12.1. Australia Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Cardiovascular Implants Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Cardiovascular Implants Market

  • 13.1. Indonesia Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Cardiovascular Implants Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Cardiovascular Implants Market

  • 14.1. South Korea Cardiovascular Implants Market Overview
  • 14.2. South Korea Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Cardiovascular Implants Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Cardiovascular Implants Market

  • 15.1. Western Europe Cardiovascular Implants Market Overview
  • 15.2. Western Europe Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Cardiovascular Implants Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Cardiovascular Implants Market

  • 16.1. UK Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Cardiovascular Implants Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Cardiovascular Implants Market

  • 17.1. Germany Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Cardiovascular Implants Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Cardiovascular Implants Market

  • 18.1. France Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Cardiovascular Implants Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Cardiovascular Implants Market

  • 19.1. Italy Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Cardiovascular Implants Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Cardiovascular Implants Market

  • 20.1. Spain Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Cardiovascular Implants Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Cardiovascular Implants Market

  • 21.1. Eastern Europe Cardiovascular Implants Market Overview
  • 21.2. Eastern Europe Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Cardiovascular Implants Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Cardiovascular Implants Market

  • 22.1. Russia Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Cardiovascular Implants Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Cardiovascular Implants Market

  • 23.1. North America Cardiovascular Implants Market Overview
  • 23.2. North America Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Cardiovascular Implants Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Cardiovascular Implants Market

  • 24.1. USA Cardiovascular Implants Market Overview
  • 24.2. USA Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Cardiovascular Implants Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Cardiovascular Implants Market

  • 25.1. Canada Cardiovascular Implants Market Overview
  • 25.2. Canada Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Cardiovascular Implants Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Cardiovascular Implants Market

  • 26.1. South America Cardiovascular Implants Market Overview
  • 26.2. South America Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Cardiovascular Implants Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Cardiovascular Implants Market

  • 27.1. Brazil Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Cardiovascular Implants Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Cardiovascular Implants Market

  • 28.1. Middle East Cardiovascular Implants Market Overview
  • 28.2. Middle East Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Cardiovascular Implants Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Cardiovascular Implants Market

  • 29.1. Africa Cardiovascular Implants Market Overview
  • 29.2. Africa Cardiovascular Implants Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Cardiovascular Implants Market, Segmentation By Material, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Cardiovascular Implants Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Cardiovascular Implants Market Competitive Landscape And Company Profiles

  • 30.1. Cardiovascular Implants Market Competitive Landscape
  • 30.2. Cardiovascular Implants Market Company Profiles
    • 30.2.1. Abbott Laboratories
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Medtronic PLC
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Boston Scientific Corporation
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. B. Braun Melsungen AG
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Edwards Lifesciences Corporation
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Cardiovascular Implants Market Other Major And Innovative Companies

  • 31.1. W. L. Gore & Associates Inc.
  • 31.2. Cook Medical Incorporated
  • 31.3. Teleflex Incorporated
  • 31.4. Kyoto Medical Planning Co. Ltd.
  • 31.5. Abiomed Inc.
  • 31.6. Livanova PLC
  • 31.7. BIOTRONIK SE & Co. KG
  • 31.8. CryoLife Inc.
  • 31.9. Endologix Inc.
  • 31.10. Sorin Group
  • 31.11. Berlin Heart GmbH
  • 31.12. REVA Medical LLC.
  • 31.13. Syncardia Systems LLC
  • 31.14. Elixir Medical Corporation
  • 31.15. Fortimedix Surgical B.V.

32. Global Cardiovascular Implants Market Competitive Benchmarking

33. Global Cardiovascular Implants Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Cardiovascular Implants Market

35. Cardiovascular Implants Market Future Outlook and Potential Analysis

  • 35.1 Cardiovascular Implants Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Cardiovascular Implants Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Cardiovascular Implants Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer